Brochure | January 15, 2019

Independent Statistical Center Function

Source: Cytel

Consistent with the latest FDA and EMA draft guidances on adaptive design, drug development sponsors are increasing their use of external independent Data Monitoring Committees (DMC’s) for their adaptive designed Late Phase clinical  trials. To carry out their mission, DMC’s require timely and accurate statistical analyses and summaries of accumulating clinical trial data.     

Independent Statistical Centers (ISC’s) provide these analyses to DMC’s.

Cytel has highly knowledgeable clinical trial statisticians, statistical programmers, and database managers with extensive ISC performance experience.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader